New Delhi, March 17 (IANS) Aurobindo Pharma on Tuesday said that the US Food and Drug Administration (USFDA) has classified one of its subsidiary units as “Official Action Indicated” (OAI) following an inspection conducted last year.In a regulatory filing, the company said that the USFDA inspected Unit-II of Eugia Pharma Specialities Limited, its wholly-owned subsidiary, located in Bhiwadi, Rajasthan, between November 3 and 14, 2025.At the end of the inspection, the regulator had issued a Fo…
Trending
- Lo Naveena Review: Humour, Heartbreak, and Friendship Shine in This Charming Kannada Entertainer
- Sattendru Maarudhu Vaanilai Review: Jai and Meenakshi Govindarajan Deliver a Wildly Entertaining Tamil Thriller You Cannot Miss
- Shikhandi (2026) Review: A Riveting Paranormal Thriller That Awakens Ancient Legends
- Sherr (2026) Movie Review: A Raw Kannada Crime Drama That Packs a Punch
- Mr. Work From Home Review: Trigun’s Bold Leap From Silicon Valley to Soil Strikes a Meaningful Chord
- Harudu (2026) Review: Venkat’s Gritty Cop Drama Delivers Raw Action and Solid Entertainment
- Kartavya Review: Saif Ali Khan Delivers a Gripping Performance in This Bold Caste-Crime Thriller on Netflix
- Karuppu Review: Suriya’s God Mode Delivers a Rousing Mass Entertainer That Hits Where It Matters Most